News & Publications

HOME  | 
  • Targeted Drug Discovery Summit- Feb. 2022.

    Founder and CEO of resistanceBio, Nick Goldner, will speak at this year’s Targeted Drug Discover Summit. The summit will take place in Boston, MA, from February 22nd to 24th. Please click on the link below for Summit details!

    Full Article

  • R-Bio is proud to be partnering with 50 Years!

    “What doesn’t kill you makes you stronger” is not just a cute saying for a throw pillow or gym shirt — it’s an actual biological phenomenon.

    Full Article

  • Check out our interview in FierceBiotech.com!

    Could a single pill treat a tumor today and head off its drug resistance mechanisms tomorrow? resistanceBio is on the case. Cancer drugs stop working when malignant cells develop molecular changes that allow them to evade the drugs’ effects.

    Full Article

  • Subclonal cooperation drives metastasis

    Most human tumours are heterogeneous, composed of cellular clones with different properties present at variable frequencies. Highly heterogeneous tumours have poor clinical outcomes, yet the underlying mechanism remains poorly understood.

    Full Article

Search


Archives


Follow Us